We’re Moving Your Greatest Idea Forward
Have an invention? Tell us about it! Please note that public disclosures such as conference abstracts and publications may preclude our ability to protect your invention. Be sure to inform OTC of any imminent or prior disclosures!
Through our partnerships with faculty, industry, entrepreneurs and investors, ensure that Duke innovations reach the marketplace for the benefit of society and to enable future investment in Duke research and innovation.
Duke will be a leader in transferring its knowledge and innovations to the worldwide community.
Faculty & Innovators
We work together to augment the impact of your innovations, build connections with industrial, entrepreneurial, legal and investment resources and amplify the value and impact of your Duke innovations.
Duke Capital Partners
The investment network of Duke alumni, faculty, and parents which provides its members with exciting opportunities to invest in early-stage companies with a Duke connection – and for Duke-affiliated entrepreneurs to pitch their companies for potential investment.
Looking for cutting-edge technology? We welcome you to browse our list of available technologies from therapeutics to imaging and software and find one that will make a difference!
Bringing your innovation to the market requires a lot of resources. We are here to guide you on available resources at Duke and beyond that will help you realize your dream.
Duke Start-up: Warden Bio
Warden Bio is developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). The GSD gene therapy is based on research led by the lab of Dr. Priya Kishnani, Chen Family Distinguished Professor & Division Chief for Medical Genetics at Duke University, in close collaboration with Dr. Aravind Asokan, Professor & Director of Gene Therapy at Duke University and Co-Founder of StrideBio. Over the past three decades, Dr. Kishnani has built an interdisciplinary team with world-leading GSD expertise whose efforts are most notably demonstrated by the long-standing research and clinical experience that resulted in FDA approval of alglucosidase alfa (Myozyme/Lumizyme) as the...
Kishnani Priya, Aravind Asokan, Sun Baodong
Duke Start-up: Solar Unsoiled
Solar Unsoiled is an interactive, data-driven platform to optimize global solar energy production. The company is maximizing solar energy profit and reducing financial risk using predictive models to mitigate the impact of energy losses due to dust and air pollution. Solar Unsoiled targets optimization surrounding the issue of detrimental soiling losses.
Duke Start-up: Basking Biosciences Inc.
Basking Bio, founded by endovascular neurosurgeon and research scientist, Shai Nimjee, is developing a drug-antidote pair for treatment of patients with ischemic stroke using technologies founded out of Duke Professor of Surgery, Bruce Sullenger’s Cardiovascular Biology Lab. Basking Biosciences is developing the only reversible anti-thrombotic therapeutic to treat ischemic stroke. Founded based on IP licensed from Duke and Ohio State Universities, DTRI-031, Basking’s lead compound, leverages the proven aptamer technology platform developed in founder Bruce Sullenger’s lab at Duke to create a highly specific inhibitor of Von Willebrand Factor (VWF) and a paired reversal agent. This paired therapy enables rapid...
Bruce Sullenger , Shai Nimjee
Reselute, founded around Duke technology by a Duke professor and graduates, is developing solutions to orthopedic infections
Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models
Ten63 is a Duke University start-up founded by Professor Bruce Donald (Computer Science, Trinity), and his students. Ten63 is also a Duke Capital Partners portfolio…
Lacuna Medical is Developing a 3D Shape Catheter that is More Resistant to Failure
Nucleate – Activator Program Apps Open – Sep 26 info session
Nucleate is a student-run nonprofit organization that facilitates the formation of new life science ventures.